Co-immunization of DNA and Protein in the Same Anatomical Sites Induces Superior Protective Immune Responses against SHIV Challenge.

ADCC DNA FcγR HIV Indian rhesus macaques antibody cellular immunity humoral immunity protein vaccine

Journal

Cell reports
ISSN: 2211-1247
Titre abrégé: Cell Rep
Pays: United States
ID NLM: 101573691

Informations de publication

Date de publication:
12 05 2020
Historique:
received: 18 12 2019
revised: 10 03 2020
accepted: 16 04 2020
entrez: 14 5 2020
pubmed: 14 5 2020
medline: 21 5 2021
Statut: ppublish

Résumé

We compare immunogenicity and protective efficacy of an HIV vaccine comprised of env and gag DNA and Env (Envelope) proteins by co-administration of the vaccine components in the same muscles or by separate administration of DNA + protein in contralateral sites in female rhesus macaques. The 6-valent vaccine includes gp145 Env DNAs, representing six sequentially isolated Envs from the HIV-infected individual CH505, and matching GLA-SE-adjuvanted gp120 Env proteins. Interestingly, only macaques in the co-administration vaccine group are protected against SHIV CH505 acquisition after repeated low-dose intravaginal challenge and show 67% risk reduction per exposure. Macaques in the co-administration group develop higher Env-specific humoral and cellular immune responses. Non-neutralizing Env antibodies, ADCC, and antibodies binding to FcγRIIIa are associated with decreased transmission risk. These data suggest that simultaneous recognition, processing, and presentation of DNA + Env protein in the same draining lymph nodes play a critical role in the development of protective immunity.

Identifiants

pubmed: 32402293
pii: S2211-1247(20)30577-5
doi: 10.1016/j.celrep.2020.107624
pmc: PMC7329227
mid: NIHMS1593927
pii:
doi:

Substances chimiques

Proteins 0
DNA 9007-49-2

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, N.I.H., Intramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

107624

Subventions

Organisme : NIAID NIH HHS
ID : UM1 AI100645
Pays : United States
Organisme : NIDA NIH HHS
ID : HHSN271201100016C
Pays : United States
Organisme : NIH HHS
ID : P51 OD011132
Pays : United States
Organisme : NIH HHS
ID : P51 OD011104
Pays : United States
Organisme : NIAID NIH HHS
ID : P01 AI120756
Pays : United States
Organisme : NIAID NIH HHS
ID : P01 AI131251
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI118549
Pays : United States
Organisme : Intramural NIH HHS
ID : Z01 BC010350
Pays : United States

Informations de copyright

Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Declaration of Interests G.N.P. and B.K.F. are inventors on US Government-owned patents related to DNA vaccines and gene expression optimization. B.F.H. has submitted patent applications covering the Envs used in this study. S.G.R. is a full-time employee of Infectious Disease Research Institute and as such receives compensation in the form of salary. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The manuscript has been reviewed by the Walter Reed Army Institute of Research. There is no objection to its presentation and/or publication. The opinions or assertions contained herein are the private views of the author, and are not to be construed as official, or as reflecting true views of the Department of the Army or the Department of Defense. The views expressed in this article are those of the authors and do not necessarily reflect the official policy of the Department of the Army, Department of Defense, or the U.S. Government. The other authors declare no competing interests. This work was produced solely by the authors and that no other individuals or entities influenced any aspects of the work.

Références

Nat Med. 2018 Oct;24(10):1590-1598
pubmed: 30177821
Cell Rep. 2017 Dec 26;21(13):3681-3690
pubmed: 29281818
Biometrics. 2016 Dec;72(4):1206-1215
pubmed: 27061097
Front Immunol. 2013 Nov 04;4:354
pubmed: 24204366
Stat Med. 2019 Sep 10;38(20):3936-3946
pubmed: 31215662
Mol Syst Biol. 2019 May 2;15(5):e8747
pubmed: 31048360
Int J Nanomedicine. 2018 Jun 26;13:3689-3711
pubmed: 29983563
Expert Rev Vaccines. 2013 May;12(5):537-54
pubmed: 23659301
Lancet. 2018 Jul 21;392(10143):232-243
pubmed: 30047376
Stat Biopharm Res. 2009 Feb 1;1(1):81-91
pubmed: 20072667
Vaccine. 2013 Aug 12;31(36):3747-55
pubmed: 23624057
Sci Transl Med. 2015 Oct 21;7(310):310rv7
pubmed: 26491081
AIDS Res Hum Retroviruses. 2012 Nov;28(11):1444-57
pubmed: 23035746
J Stat Softw. 2010;33(1):1-22
pubmed: 20808728
PLoS One. 2013;8(1):e53629
pubmed: 23349725
Clin Immunol. 2014 Aug;153(2):308-22
pubmed: 24907411
J Immunol Methods. 2014 Feb;404:1-12
pubmed: 24316020
Sci Transl Med. 2017 Jun 7;9(393):
pubmed: 28592561
J Virol. 2008 Dec;82(24):12449-63
pubmed: 18842730
Proc Natl Acad Sci U S A. 2013 Feb 19;110(8):2975-80
pubmed: 23359688
Clin Immunol. 2014 Nov;155(1):91-107
pubmed: 25229164
J Virol. 2015 Aug;89(16):8643-50
pubmed: 26018159
Antimicrob Agents Chemother. 2002 Jun;46(6):1896-905
pubmed: 12019106
J Virol. 2016 Nov 28;90(24):10993-11006
pubmed: 27630234
PLoS Pathog. 2019 Sep 17;15(9):e1008026
pubmed: 31527908
Immunol Rev. 2017 Jan;275(1):5-10
pubmed: 28133795
Immunol Rev. 2017 Jan;275(1):262-270
pubmed: 28133810
Nature. 2012 Jan 04;482(7383):89-93
pubmed: 22217938
Nat Commun. 2017 Jun 08;8:15711
pubmed: 28593989
J Clin Invest. 2019 Nov 1;129(11):4838-4849
pubmed: 31589165
Immunol Rev. 2017 Jan;275(1):145-160
pubmed: 28133802
PLoS One. 2017 Oct 11;12(10):e0177863
pubmed: 29020058
Nat Commun. 2017 Nov 23;8(1):1732
pubmed: 29170366
J Virol. 1998 Apr;72(4):2855-64
pubmed: 9525605
J Virol. 2008 Dec;82(24):12585-8
pubmed: 18842727
Nat Med. 2016 Jul;22(7):762-70
pubmed: 27239761
Methods Mol Biol. 2009;485:395-405
pubmed: 19020839
Vaccines (Basel). 2014 May 14;2(2):354-79
pubmed: 26344623
Hum Vaccin Immunother. 2012 Nov 1;8(11):1620-9
pubmed: 22894956
Immunity. 2017 Jun 20;46(6):1073-1088.e6
pubmed: 28636956
J Immunol Methods. 2017 Apr;443:33-44
pubmed: 28163018
Proc Natl Acad Sci U S A. 2009 Sep 15;106(37):15831-6
pubmed: 19717425
N Engl J Med. 2012 Apr 5;366(14):1275-86
pubmed: 22475592
Vaccine. 2008 Jun 13;26(25):3112-20
pubmed: 18430495
Vaccine. 2003 Jan 30;21(7-8):629-37
pubmed: 12531331
Cell. 2016 Apr 7;165(2):449-63
pubmed: 26949186
Vaccine. 2014 Jan 16;32(4):507-13
pubmed: 24280279
Cytometry A. 2011 Aug;79(8):603-12
pubmed: 21735545
PLoS One. 2014 Dec 16;9(12):e113463
pubmed: 25514675
Sci Transl Med. 2019 Aug 28;11(507):
pubmed: 31462510
Proc Natl Acad Sci U S A. 2014 Jul 15;111(28):10275-80
pubmed: 24982157
N Engl J Med. 2009 Dec 3;361(23):2209-20
pubmed: 19843557
PLoS One. 2014 Mar 13;9(3):e91550
pubmed: 24626482
J Virol. 2005 Jul;79(13):8480-92
pubmed: 15956591
J Virol. 2011 Jul;85(14):7029-36
pubmed: 21543485
J Immunol. 2016 Nov 15;197(10):3999-4013
pubmed: 27733554
J Virol. 2011 Oct;85(19):9998-10009
pubmed: 21795340
Cell. 2014 Jul 31;158(3):481-91
pubmed: 25065977
Curr Opin Immunol. 2017 Aug;47:64-69
pubmed: 28738289
Immunol Rev. 2017 Jan;275(1):245-261
pubmed: 28133811
Nature. 2012 Oct 18;490(7420):417-20
pubmed: 22960785
AIDS. 2014 Jan 14;28(2):163-9
pubmed: 24361678
Immunol Rev. 2017 Jan;275(1):79-88
pubmed: 28133807
Lancet HIV. 2019 Nov;6(11):e737-e749
pubmed: 31601541
Cell Host Microbe. 2018 Jul 11;24(1):25-33
pubmed: 30001521
Proc Natl Acad Sci U S A. 2016 Jun 14;113(24):E3413-22
pubmed: 27247400
Immunity. 2018 May 15;48(5):855-871
pubmed: 29768174
Immunity. 2019 Jan 15;50(1):241-252.e6
pubmed: 30552025
J Immunol Methods. 2015 Oct;425:27-36
pubmed: 26078040
Cell Rep. 2017 Feb 28;18(9):2175-2188
pubmed: 28249163
Vaccine. 2012 Feb 21;30(9):1737-45
pubmed: 22178526
PLoS Pathog. 2018 Nov 5;14(11):e1007431
pubmed: 30395637
J Infect Dis. 2010 Aug 15;202(4):595-605
pubmed: 20608874
J Virol Methods. 2000 Apr;86(1):61-70
pubmed: 10713377
Science. 2015 Jul 17;349(6245):320-4
pubmed: 26138104
Cell Rep. 2016 Nov 22;17(9):2195-2209
pubmed: 27880897
J Virol. 2010 Jul;84(14):7161-73
pubmed: 20444898
J Virol. 2018 Jul 17;92(15):
pubmed: 29793957
J Biol Chem. 2013 Mar 1;288(9):6763-76
pubmed: 23297419
J Clin Invest. 2019 Nov 1;129(11):4769-4785
pubmed: 31566579
Cold Spring Harb Perspect Biol. 2018 May 1;10(5):
pubmed: 28630077
Nat Med. 2018 Jun;24(6):857-867
pubmed: 29867235
PLoS One. 2012;7(2):e31464
pubmed: 22359593
J Virol. 2009 Aug;83(16):8289-92
pubmed: 19474095
J Virol. 2000 Sep;74(18):8358-67
pubmed: 10954535
PLoS One. 2013 Dec 31;8(12):e84234
pubmed: 24391921
Nature. 2013 Apr 25;496(7446):469-76
pubmed: 23552890
J Immunol. 2009 Mar 15;182(6):3718-27
pubmed: 19265150
J Virol. 2009 Jan;83(2):791-801
pubmed: 18971271

Auteurs

Barbara K Felber (BK)

Human Retrovirus Pathogenesis Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, MD 21702, USA. Electronic address: barbara.felber@nih.gov.

Zhongyan Lu (Z)

Human Retrovirus Pathogenesis Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, MD 21702, USA.

Xintao Hu (X)

Human Retrovirus Pathogenesis Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, MD 21702, USA.

Antonio Valentin (A)

Human Retrovirus Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, MD 21702, USA.

Margherita Rosati (M)

Human Retrovirus Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, MD 21702, USA.

Christopher A L Remmel (CAL)

Thayer School of Engineering, Dartmouth College, Hanover, NH 03755, USA.

Joshua A Weiner (JA)

Thayer School of Engineering, Dartmouth College, Hanover, NH 03755, USA.

Margaret C Carpenter (MC)

Thayer School of Engineering, Dartmouth College, Hanover, NH 03755, USA.

Katelyn Faircloth (K)

Thayer School of Engineering, Dartmouth College, Hanover, NH 03755, USA.

Sherry Stanfield-Oakley (S)

Duke Human Vaccine Institute, Duke University, Durham, NC 27710, USA; Department of Surgery, Duke University, Durham, NC 27710, USA; Department of Molecular Genetics and Microbiology, Duke University, Durham, NC 27710, USA.

Wilton B Williams (WB)

Duke Human Vaccine Institute, Duke University, Durham, NC 27710, USA.

Xiaoying Shen (X)

Duke Human Vaccine Institute, Duke University, Durham, NC 27710, USA.

Georgia D Tomaras (GD)

Duke Human Vaccine Institute, Duke University, Durham, NC 27710, USA; Department of Surgery, Duke University, Durham, NC 27710, USA; Department of Molecular Genetics and Microbiology, Duke University, Durham, NC 27710, USA; Department of Immunology, Duke University, Durham, NC 27710, USA.

Celia C LaBranche (CC)

Duke Human Vaccine Institute, Duke University, Durham, NC 27710, USA; Department of Surgery, Duke University, Durham, NC 27710, USA.

David Montefiori (D)

Duke Human Vaccine Institute, Duke University, Durham, NC 27710, USA; Department of Surgery, Duke University, Durham, NC 27710, USA.

Hung V Trinh (HV)

U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD 20910, USA; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD 20817, USA.

Mangala Rao (M)

U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD 20910, USA.

Munir S Alam (MS)

Duke Human Vaccine Institute, Duke University, Durham, NC 27710, USA.

Nathan A Vandergrift (NA)

Duke Human Vaccine Institute, Duke University, Durham, NC 27710, USA.

Kevin O Saunders (KO)

Duke Human Vaccine Institute, Duke University, Durham, NC 27710, USA; Department of Surgery, Duke University, Durham, NC 27710, USA.

Yunfei Wang (Y)

Duke Human Vaccine Institute, Duke University, Durham, NC 27710, USA.

Wes Rountree (W)

Duke Human Vaccine Institute, Duke University, Durham, NC 27710, USA.

Jishnu Das (J)

Ragon Institute of MGH, MIT and Harvard, Cambridge, MA 02139, USA.

Galit Alter (G)

Ragon Institute of MGH, MIT and Harvard, Cambridge, MA 02139, USA.

Steven G Reed (SG)

Infectious Disease Research Institute, Seattle, WA 98102, USA.

Pyone P Aye (PP)

Division of Comparative Pathology, Tulane National Primate Research Center, Covington, LA 70433, USA.

Faith Schiro (F)

Division of Comparative Pathology, Tulane National Primate Research Center, Covington, LA 70433, USA.

Bapi Pahar (B)

Division of Comparative Pathology, Tulane National Primate Research Center, Covington, LA 70433, USA.

Jason P Dufour (JP)

Division of Comparative Pathology, Tulane National Primate Research Center, Covington, LA 70433, USA.

Ronald S Veazey (RS)

Division of Comparative Pathology, Tulane National Primate Research Center, Covington, LA 70433, USA.

Preston A Marx (PA)

Tulane National Primate Research Center, and Department of Tropical Medicine, School of Public Health and Tropical Medicine, Tulane University, New Orleans, LA 70112, USA.

David J Venzon (DJ)

Biostatistics and Data Management Section, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.

George M Shaw (GM)

Departments of Medicine and Microbiology, University of Pennsylvania, Philadelphia, PA 19104, USA.

Guido Ferrari (G)

Duke Human Vaccine Institute, Duke University, Durham, NC 27710, USA; Department of Surgery, Duke University, Durham, NC 27710, USA; Department of Molecular Genetics and Microbiology, Duke University, Durham, NC 27710, USA.

Margaret E Ackerman (ME)

Thayer School of Engineering, Dartmouth College, Hanover, NH 03755, USA.

Barton F Haynes (BF)

Duke Human Vaccine Institute, Duke University, Durham, NC 27710, USA; Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA. Electronic address: barton.haynes@duke.edu.

George N Pavlakis (GN)

Human Retrovirus Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, MD 21702, USA. Electronic address: george.pavlakis@nih.gov.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH